⚡ Webinar Synopsis: In this webinar, we talk about Good Clinical Practice being implemented into OracleBio and our journey thus far.
📩 Newsletter: Subscribe now for the latest Webinars, Videos, Articles & more! →
Good clinical practice (GCP) is an internationally recognised ethical and scientific standard for designing, recording and reporting trials that involve the participation of human subjects. For quantitative image analysis data to be included in a data package submitted to regulatory authorities, it is essential that it is generated using a workflow that is in accordance with GCP principles.
OracleBio have recently launched GCP Image Analysis Services, the implementation of which was driven by Clinical Operations Manager, Alison Bigley. In this webinar, Alison will share insights from the GCP implementation journey and discuss:
- Key drivers in the implementation of GCP for Quantitative Image Analysis
- Why GCP is important and the benefits of working to GCP
- What is involved in conducting Quantitative Image Analysis Studies in accordance with GCP
Learn more about our GCP services by downloading our GCP Services Brochure below:

Alison Bigley
Clinical Operations Manager
Alison Bigley is OracleBio’s Clinical Operations Manager and recently led the implementation of GCP services at the company. Alison previously spent 25 years at AstraZeneca, where she established and led a global digital pathology platform which included programming in proprietary software, application development and GxP validation. Alison has considerable experience in histology, immunohistochemistry and imaging on projects across various therapeutic areas involving pre-clinical, safety and translational medicine.
More from OracleBio:
A Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies
This poster, created in collaboration with Bristol Myers Squibb, details OracleBio's robust image analysis workflow in Indica Labs HALO, and how it helped overcome common technical issues encountered in a large multiplex IF (mIF) non-small cell lung cancer (NSCLC)...
Comparative multiplex digital phenotyping of the tumour microenvironment across multiple tumour types using a well characterized multi-tumour tissue microarray
OracleBio 8-plex TMA analysis data is presented at the AACR Virtual Annual Meeting in April 2021 and the Digital Pathology & AI Congress: Europe in December 2021. The poster, produced in collaboration with Ultivue and TriStar Technology Group, focuses on the...
High Throughput Tissue Imaging and Phenotyping by Streamlined 8-plex Staining and Analysis of Complex TMA Samples
OracleBio 8-plex TMA analysis data is presented at the Society for the Immunotherapy of Cancer (SITC) Virtual Annual Meeting in November 2020. The poster, produced in collaboration with Ultivue and TriStar Technology Group, focuses on the analysis of multi-tumour...
Find out more about our Multiplex IF Analysis
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more



